0.10
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Market Closed
Best deals to access real time data! |
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protokinetix Inc (QB) | PKTX | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 0.10 | 0.00 | 0.00 | 0.00 | 0.10 | 08:46:58 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 0.0951 | 0.10 | 0.005 | 5.0% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.10 | USD |
Protokinetix (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 27.76M | 277.62M | 147.03M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 51.69k | $ - | 0.00% | - | - |
Protokinetix (QB) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PKTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.109 | 0.109 | 0.08 | 0.0909256 | 122,381 | -0.009 | -8.26% |
| 1 Month | 0.13 | 0.13 | 0.08 | 0.1039647 | 79,559 | -0.03 | -23.08% |
| 3 Months | 0.101 | 0.1402 | 0.08 | 0.1065487 | 71,604 | -0.001 | -0.99% |
| 6 Months | 0.091 | 0.22 | 0.08 | 0.1427425 | 95,981 | 0.009 | 9.89% |
| 1 Year | 0.25285 | 0.289 | 0.08 | 0.1439196 | 93,320 | -0.15285 | -60.45% |
| 3 Years | 0.0679 | 0.32 | 0.03 | 0.1209016 | 102,226 | 0.0321 | 47.28% |
| 5 Years | 0.0642 | 0.32 | 0.0201 | 0.1015199 | 109,883 | 0.0358 | 55.76% |
Protokinetix (QB) Description
| ProtoKinetix is a molecular biotechnology company that has developed and patented a family of hyper stable, potent glycopeptides (AAGP) that enhance both engraftment and protection of transplanted cells, tissues and organs used in regenerative medicine. Due to the results achieved over the last four years of testing, the University of Alberta has begun Phase 1 human clinical trial. Additional studies will be expanded to include whole organ transplantation and all therapies that are being developed globally to date; diabetes, retinal degeneration, cardiac repair and many other degenerative conditions. In addition, we are studying the potential impact on several cancer therapies. |
